Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bruker unveils high performance GC CARE Columns
The new high quality GC Columns offer a wide variety of column chemistries and are designed for applications in petrochemical, environmental testing, food safety, flavor and fragrance analysis,
The new high quality GC Columns offer a wide variety of column chemistries and are designed for applications in petrochemical, environmental testing, food safety, flavor and fragrance analysis,
Sativex is indicated for spasticity in MS patients who have not responded adequately to other treatments. It is administered as oromucosal spray enabling flexible dosage, which is particularly
The company’s net loss was $1.3m, compared to a net loss of $2.41m for the same period in 2009. Antares Pharma has reported operating loss of $1.23m for
OncoSec will pay Inovio an undisclosed purchase price for the assigned assets and cash fees and a royalty on commercial product sales. The electroporation technology being sold and
Most recently, Robinson has worked as the CEO of WorkWell Systems and held senior roles at UnitedHealth Group, Deloitte Consulting and PriceWaterhouseCoopers in his career. LifeVantage board of
AN2728 is a boron-based small-molecule compound which reduces the production pro-inflammatory cytokines that are the precursors of the inflammation associated with psoriasis. The double-blind, randomised, vehicle-controlled Phase 2b
The Phase I open-label, dose-escalation study will dose up to 16 patients and will determine the maximum tolerated dose (MTD) of Imprime PGG in combination with alemtuzumab and
The company has generated net income of $13.32m, compared to a net income of $1.74m for the same period in 2009. Medidata has reported operating income of $9.91m
According to Bayer HealthCare, Gadavist demonstrated improvement of visualization endpoints in paired Gadavist images compared to pre-contrast images resulted in improved assessment of normal and abnormal CNS anatomy
The patent (US 7,902,152), entitled ‘Use of cobratoxin as an analgesic,’ describes a composition of matter for an analgesia and its method of use. The method of use